In this study, we extracted total RNA from 15 intracranial aneurysms and 17 superficial temporal artery samples, then performed genome-wide expression profiling using the Affymetrix U133 Plus 2.0 GeneChip. Genes that were differentially expressed between intracranial aneurysms and arterial samples were identified using significance analysis for microarrays, and the expression patterns of three randomly-selected genes were verified by real-time polymerase chain reaction analysis. We identifi ed 3 736 differentially-expressed genes out of the 47 000 assayed transcripts. A total of 179 genes showed a >10-fold change in expression between the aneurysms and the arterial samples. Genes involved in the proliferation, migration, and apoptosis of vascular muscle cells, atherosclerosis, extracellular matrix disruption, and inflammatory reactions were associated with the formation of intracranial aneurysms. There were no significant differences in gene expression profile between unruptured and ruptured aneurysms.
INTRODUCTION
Aneurysmal subarachnoid hemorrhage is an event with high mortality and morbidity. It accounts for 3-11% of all stroke cases [1, 2] , and causes death in 5% and disability in 25% of stroke patients. The prevalence of intracranial aneurysms is ~1% in adults [3] [4] [5] [6] . Studies have shown that inconsistent results [7] [8] [9] [10] [11] . Defects or aberrant changes in gene transcription and translation underlie the development of many diseases, since they regulate the structure, concentration, and activity of specifi c proteins in diseaserelated tissues. Thus, gene expression changes in intracranial aneurysms have received widespread attention in recent years. However, there has been limited success in identifying the significance of gene expression in aneurysms, due to ethnic differences underlying differential gene-expression profi les and diffi culties in tissue-sampling and control selection. For example, aneurysm tissues were obtained from autopsies in some studies [12] , and controls were obtained from diverse tissues, such as the superfi cial temporal artery [13] , the middle meningeal artery [14] , normal arteries adjacent to an arteriovenous malformation [15] , and other intracranial arteries [16] . In this study, we obtained aneurysm tissue samples from 15 patients and superfi cial temporal artery samples from 17 patients as a control during surgery, and examined the gene expression profi les using cDNA microarray-based methods.
PARTICIPANTS AND METHODS

Informed Consent and Ethics Committee Approval
All experimental protocols in this study were approved by the fi nally scanned with a GeneChip Scanner 3000 (Affymetrix).
Microarray Analysis
Affymetrix GeneChip Human Genome U133 Plus 2.0 software was used to analyze gene transcription in human vascular tissues. This array covers ~38 500 human genes and assays ~47 000 transcripts.
Data generated by the GeneChip Scanner 3000 were then transformed with Affymetrix GeneChip Command
Console software (Affymetrix), and saved as .CEL files.
Transformed data pre-processing (background correction, normalization, and expression level calculation) was performed using Robust Multiarray Analysis. Significance analysis of microarrays (SAM) was used to select genes that exhibited differential expression between the aneurysm-derived and arterial samples, and the R language pack was used to calculate the significance of such differences (q value). A significant difference was defi ned as a fold-change >2 and q <0.01.
Real-time Quantitative PCR (qPCR)
We further randomly selected three differentially-expressed genes (TLR4, MYD88, and IRAK-1), and obtained their fulllength cDNA sequences from Genbank. PCR primers were designed by Capital Biochip Corp., Beijing. The expression of these genes in the aneurysms and arterial samples was analyzed by real-time qPCR using the ABI 7900HT Fast
Real-Time PCR System (Applied Biosystems, Foster City, CA) to verify the results of the GeneChip analysis.
RESULTS
Clinical Features
All 32 patients were of Han-Chinese origin. Clinical data are summarized in Table 1 . The locations of the intracranial aneurysms in the experimental group were: anterior cerebral artery (13.3%, n = 2), anterior communicating artery (13.3%, n = 2), middle cerebral artery (26.7%, n = 4), internal carotid artery (13.3%, n = 2), and multiple sites (33.3%, n = 5).
Based on the history of aneurysm rupture, patients in the experimental group comprised: unruptured aneurysm (40%, n = 6), primary aneurysm rupture (46.7%, n = 7), and secondary aneurysm rupture (13.3%, n = 2).
The aneurysm diameters in the experimental group were: small (≤5 mm) (33.3%, n = 5), medium (6-15 mm) (26.7%, n = 4), large (16-25 mm) (6.7%, n = 1), and huge (>25 mm) (33.3%, n = 5).
There were no signifi cant differences in age, gender, comorbidities, and medication history between the experimental and control groups.
Nucleotide Extraction
After purification, RNA extraction yielded 0.21-10.30 μg RNA, with RNA integrity numbers >6.60 and A 260 :A 280 ratios close to 1.
Microarray Quality Control
For the 32 arrays, the average background was 41.85
(range 40.58-44.00); the average noise signal was 1.47
(range 1.33-1.68); and the average 3'/5' ratio was 1.46
(range 1.08-2.24).
Cluster Analysis
Cluster analysis was performed using 
Gene Expression Profi les
A total of 3 736 differentially-expressed transcripts [foldchange ≥2, false discovery rate (FDR) <0.01] were identifi ed using SAM, and 179 showed a ≥10-fold change (FDR <0.01). Among all differentially-expressed transcripts in aneurysms, the greatest up-regulation reached 88.1-fold (COL11A1), and the greatest down-regulation reached 59.9-fold (RERGL).
Real-time qPCR
The real-time qPCR analysis revealed fold-changes in the expression of TLR4 (encoding Toll-like receptor 4), MYD88
(encoding myeloid differentiation primary response 88), 
DISCUSSION
Stroke is the third leading cause of death world-wide. The annual incidence rate of intracranial aneurysms is 2%, and these cause 500 000 cases of stroke, resulting in severe neurological dysfunction and even death [17] . Family and twin studies have found that the incidence of intracranial hemorrhage in twins with intracranial aneurysms is four times higher than that in the general population [18] , indicating the importance of genetic factors in their development.
However, no major genotypes or mutations have been confirmed to be associated with intracranial aneurysms based on genome-wide linkage and candidate-gene studies [3] . Studies have also examined the gene expression profiles in intracranial aneurysms to identify differentiallyexpressed genes, albeit with limited success, due to diffi culties in tissue sampling and control selection [12, [14] [15] [16] 19] .
Also, inconsistent results were obtained due to racial differences in gene expression profiles, which hampered the identification of aneurysm-specific changes in gene expression.
Here, we used a microarray-based method to reveal the gene expression profiles in intracranial aneurysms (experimental) and superficial temporal artery (control) samples from Han-Chinese patients. SAM identifi ed 3 736 differentially-expressed genes (fold-change ≥2, FDR <0.01), of which 179 showed >10-fold changes and had FDRs <0.01 (Table 2) . Among all the differentially-expressed transcripts, the most marked up-regulation reached 88.092-fold (COL11A1), and the greatest down-regulation reached
59.880-fold (RERGL).
Increasing numbers of studies have demonstrated that the proliferation, migration, and apoptosis of vascular muscle cells, atherosclerosis, extracellular matrix (ECM) destruction, and inflammatory reactions are associated with the formation of intracranial aneurysms [20] [21] [22] [23] . Among the 179 genes that exhibited significant differences in expression levels between aneurysms and arterial samples The formation of intracranial aneurysms has been associated with vessel-wall damage caused by lymphocytes, antibodies, and complement-induced inflammatory reactions [20, 21] . Immune and inflammatory reactions can cause leukocyte adhesion, which then stimulates immune responses and the subsequent secretion of various inflammatory factors and proteolytic enzymes, which results in vascular wall damage. Chemokines are a class of small chemotactic molecules that interact with their All q-values were 0%. These genes were reported to participate in atherosclerosis, extracellular matrix destruction, and inflammatory reactions, which are associated with the formation of aneurysm.
receptors to recruit and activate inflammatory cells such as neutrophils, lymphocytes, monocytes, and dendritic cells [24] . In this study, we not only identified up-regulated chemokine genes, such as CCL18, CCL3, CCL3L3, and Since human intracranial arteries lack an external elastic lamina, disruption of the ECM, which provides strength and elasticity, is suggested to play a role in the pathogenesis of intracranial aneurysms [22] . The ECM of the arterial wall contains collagen, elastic and reticular fi bers, as well as a variety of non-collagenous sugar proteins.
The ECM helps maintain the elasticity and resistanceto-expansion of the vessel wall, and participates in the regulation of endothelial and muscle cell functions by interacting with vascular wall cells. Collagen is assembled through the twisting of 3 polypeptide strands (α1, α2, and α3), and based on the structure of these strands, collagen can be classified into 27 types. There are 5 types of collagen in the arterial wall: types I, III, IV, V, and VI. Types I and III account for 80-90% of the total collagen in the arterial wall, and type III is the major factor contributing to the tensile properties of the arterial wall [25] . Here, we found that COL1A1 (encoding collagen type I, α1) was significantly up-regulated, while COL4A6 (encoding collagen type IV, α6) was significantly down-regulated in aneurysms. Type III is often co-expressed with type I in many tissues, and can form heterologous fi brils with type I.
The diameter of the collagen fi bril is negatively correlated with the ratio of type III to type I, and a higher III/I ratio leads to a fi ner fi bril and a more pliant artery. The decrease in expression of type III and the concomitant increase in expression of type I would result in a decreased III/I ratio, thereby causing vessel dilation and the formation of aneurysms [22] .
Apolipoprotein abnormalities can cause abnormal blood lipid levels and induce atherosclerosis, which then leads to intracranial arterial wall damage and decreases arterial resistance to expansion, and finally, intracranial ApoE4 increases it, thereby promoting the development of atherosclerosis, and is therefore a risk factor for atherosclerosis [23] .
In accord with the data reported in previous studies [12, [14] [15] [16] 19] , our results showed that genes with differential expression in aneurysms are mainly involved in immune and inflammatory processes, in cell growth, proliferation, differentiation and migration, as well as in intercellular signal transduction. We also found that these genes were most highly correlated with immune cell traffi cking, tissue morphology, humoral immune responses, and blood and cardiovascular system development.
However, we found no significant differences in the gene expression profiles of unruptured and ruptured aneurysms, which contradicts previous findings [16] . The 105 inconsistent results might be explained by the development of microarray technology, differences in the number of samples, different statistical methods, and by differences in control selection. For instance, Weinsheimer et al. [12] used intracranial vascular samples from autopsies; Krischek et al. [15] used arteriovenous malformations in the feeding artery; Shi et al. [19] used the superfi cial temporal artery; and Pera et al. [16] used meningeal artery samples as controls. All these arteries differ from intracranial vascular samples in both structure and hemodynamics. Also, racial differences in the participants in various studies are another important factor that may yield inconsistent results. Our study had a few limitations. First, the sample size was small, especially when aneurysms were divided into ruptured and unruptured groups. Second, the microarray results need to be verifi ed by other experimental methods, such as real-time qPCR and immunohistochemistry. We verified the differential expression in three randomly-selected genes using realtime qPCR. Further validation of the microarray data and analysis of a larger number of samples is required in future studies to address the role of gene expression changes in the pathogenesis and progression of aneurysms.
In sum, the results of our study suggest that the genes differentially expressed in aneurysms are mainly those involved in immune and inflammatory responses, in cell growth, proliferation, differentiation, and migration, and in intercellular signal transduction. We also found that these genes were most-highly correlated with immune celltraffi cking, tissue morphology, humoral immune responses, and blood and cardiovascular system development. In contrast to the results of previous studies, our findings showed no significant differences in gene expression profi les between unruptured and ruptured aneurysms.
